Olesen Drachmann

BACKGROUND We have previously described CLDN6 as a tumor suppressor gene in breast cancer. Here, a new finding is that CLDN6 was upregulated under hypoxia, a commonly recognized factor that promotes tumor metastasis. In this study, we aim to explain this confusing finding and delineate the role of CLDN6 in the breast cancer metastasis induced by…[Read more]

Patients with follow-up MLHFQ scores demonstrated improvements in QoL, despite increasingly complex medication regimens. Medication regimen complexity alone is likely an insufficient marker for predicting QoL in patients with HF. BACKGROUND An accurate medication history is crucial for maintaining continuity of care. Cell Cycle inhibitor There are…[Read more]

The corresponding mechanism function was f(α) = 1, the apparent activation energy (Eα) was 51.56 kJ/mol, and the kinetics equation was k = 3.14exp(- 51.56/RT). Using the SRMS technology, magnetite gradually formed from hematite, starting at the outer particle layers and moving inward toward the core. The microcracks and pores in the surface of t…[Read more]

This study aims to explore the prevalence of and factors associated with cardiometabolic risks and lung function impairment among middle-aged women.

A nurse-led community health development and cross-sectional study design was applied in Yunlin County, Taiwan. Lung function test was performed by a certified technician using a valid…[Read more]

Recent studies have demonstrated that inhibition of CD26 potentiates stromal cell-derived factor-1α (SDF-1α) promotes tissue regeneration and suppresses the rejection of organ transplants. This study investigated whether the combination of a CD26 inhibitor (CD26i) with granulocyte colony-stimulating factor (G-CSF) and short-term i…[Read more]